FI20001775A - Välituotteina käyttökelpoisia iminosubstituoituja syklopent/b/indolijohdannaisia - Google Patents

Välituotteina käyttökelpoisia iminosubstituoituja syklopent/b/indolijohdannaisia Download PDF

Info

Publication number
FI20001775A
FI20001775A FI20001775A FI20001775A FI20001775A FI 20001775 A FI20001775 A FI 20001775A FI 20001775 A FI20001775 A FI 20001775A FI 20001775 A FI20001775 A FI 20001775A FI 20001775 A FI20001775 A FI 20001775A
Authority
FI
Finland
Prior art keywords
intermediates
imino
indole derivatives
derivatives useful
useful
Prior art date
Application number
FI20001775A
Other languages
English (en)
Swedish (sv)
Other versions
FI107919B (fi
Inventor
Ong Helen Hu
Gerard Joseph O'malley
Michael Clayton Merriman
Mark Gabriel Palermo
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI20001775A publication Critical patent/FI20001775A/fi
Application granted granted Critical
Publication of FI107919B publication Critical patent/FI107919B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20001775A 1991-01-18 2000-08-10 Välituotteina käyttökelpoisia iminosubstituoituja syklopent[b]indolijohdannaisia FI107919B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64295291 1991-01-18
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (2)

Publication Number Publication Date
FI20001775A true FI20001775A (fi) 2000-08-10
FI107919B FI107919B (fi) 2001-10-31

Family

ID=24578739

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920192A FI102174B (fi) 1991-01-18 1992-01-16 Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent£b|i ndolijohdannaisten valmistamiseksi
FI20001775A FI107919B (fi) 1991-01-18 2000-08-10 Välituotteina käyttökelpoisia iminosubstituoituja syklopent[b]indolijohdannaisia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI920192A FI102174B (fi) 1991-01-18 1992-01-16 Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent£b|i ndolijohdannaisten valmistamiseksi

Country Status (26)

Country Link
US (1) US5100891A (fi)
EP (1) EP0496314B1 (fi)
JP (1) JP2665422B2 (fi)
KR (1) KR100230881B1 (fi)
AT (1) ATE158790T1 (fi)
AU (1) AU650315B2 (fi)
BR (1) BR9200171A (fi)
CA (1) CA2059610C (fi)
CZ (1) CZ282732B6 (fi)
DE (1) DE69222444T2 (fi)
DK (1) DK0496314T3 (fi)
ES (1) ES2109953T3 (fi)
FI (2) FI102174B (fi)
GR (1) GR3025318T3 (fi)
HU (1) HUT67027A (fi)
IE (1) IE920149A1 (fi)
IL (1) IL100693A0 (fi)
MX (1) MX9200206A (fi)
NO (1) NO178397C (fi)
NZ (1) NZ241305A (fi)
PH (1) PH31429A (fi)
PL (2) PL169417B1 (fi)
RO (1) RO112505B1 (fi)
RU (1) RU2077530C1 (fi)
TW (1) TW198024B (fi)
ZA (1) ZA92341B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
EP0997458A4 (en) * 1997-07-03 2003-03-05 Asahi Chemical Ind NOVEL TRICYCLIC COMPOUNDS HAVING SATUROUS CORES AND MEDICINAL COMPOSITIONS CONTAINING THEM
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
KR20010071844A (ko) * 1998-10-06 2001-07-31 디르크 반테 의약으로서의 트리사이클릭 δ3-피페리딘
IT1317926B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
AU2004247676A1 (en) 2003-06-10 2004-12-23 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
WO2005005386A1 (en) * 2003-06-12 2005-01-20 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
MX2007006179A (es) * 2004-11-23 2007-06-20 Ptc Therapeutics Inc Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (fi) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
KR100230881B1 (ko) 1999-11-15
HU9200172D0 (en) 1992-04-28
DK0496314T3 (da) 1998-05-18
DE69222444T2 (de) 1998-06-04
KR920014777A (ko) 1992-08-25
NO920235L (no) 1992-07-20
NO920235D0 (no) 1992-01-17
GR3025318T3 (en) 1998-02-27
IE920149A1 (en) 1992-07-29
CZ282732B6 (cs) 1997-09-17
RO112505B1 (ro) 1997-10-30
RU2077530C1 (ru) 1997-04-20
NO178397C (no) 1996-03-20
PL169417B1 (pl) 1996-07-31
CA2059610C (en) 2002-04-02
FI107919B (fi) 2001-10-31
MX9200206A (es) 1992-08-01
TW198024B (fi) 1993-01-11
FI920192A0 (fi) 1992-01-16
ES2109953T3 (es) 1998-02-01
FI102174B1 (fi) 1998-10-30
BR9200171A (pt) 1992-10-06
PH31429A (en) 1998-11-03
HUT67027A (en) 1995-01-30
FI102174B (fi) 1998-10-30
FI920192A (fi) 1992-07-19
DE69222444D1 (de) 1997-11-06
IL100693A0 (en) 1992-09-06
PL293209A1 (en) 1993-04-05
JP2665422B2 (ja) 1997-10-22
NZ241305A (en) 1994-10-26
CS12992A3 (en) 1992-08-12
NO178397B (no) 1995-12-11
ZA92341B (en) 1992-09-30
PL296651A1 (en) 1993-07-26
PL167465B1 (pl) 1995-09-30
US5100891A (en) 1992-03-31
AU1027992A (en) 1992-07-23
EP0496314A1 (en) 1992-07-29
EP0496314B1 (en) 1997-10-01
JPH04334367A (ja) 1992-11-20
ATE158790T1 (de) 1997-10-15
CA2059610A1 (en) 1992-07-19
AU650315B2 (en) 1994-06-16

Similar Documents

Publication Publication Date Title
FI20001775A (fi) Välituotteina käyttökelpoisia iminosubstituoituja syklopent/b/indolijohdannaisia
PT669920E (pt) 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DK0517221T3 (da) ((Arylalkylpiperidin-4-yl)-methyl)-2alfa,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-oner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO983285D0 (no) Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse
FI956151A0 (fi) Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
CA2292920A1 (fr) Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2058761T3 (es) Proceso para la preparacion de derivados de dibenzodioxazecina y dibenzodioxaazacicloundecina.